These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The ACE 2 activator diminazene aceturate (DIZE) improves left ventricular diastolic dysfunction following myocardial infarction in rats. Castardeli C; Sartório CL; Pimentel EB; Forechi L; Mill JG Biomed Pharmacother; 2018 Nov; 107():212-218. PubMed ID: 30092400 [TBL] [Abstract][Full Text] [Related]
3. Is the cardioprotective effect of the ACE2 activator diminazene aceturate more potent than the ACE inhibitor enalapril on acute myocardial infarction in rats? Badae NM; El Naggar AS; El Sayed SM Can J Physiol Pharmacol; 2019 Jul; 97(7):638-646. PubMed ID: 30840489 [TBL] [Abstract][Full Text] [Related]
4. Angiotensin-converting enzyme 2 (ACE2) activator diminazene aceturate ameliorates endotoxin-induced uveitis in mice. Qiu Y; Shil PK; Zhu P; Yang H; Verma A; Lei B; Li Q Invest Ophthalmol Vis Sci; 2014 May; 55(6):3809-18. PubMed ID: 24854854 [TBL] [Abstract][Full Text] [Related]
5. Effect of Diminazene Aceturate, an ACE2 activator, on platelet CD40L signaling induced glial activation in rat model of hypertension. Tiwari P; Elgazzaz M; Lazartigues E; Hanif K Int Immunopharmacol; 2024 Sep; 139():112654. PubMed ID: 38996777 [TBL] [Abstract][Full Text] [Related]
6. Cardioprotective effects of diminazene aceturate in pressure-overloaded rat hearts. Macedo LM; Souza ÁP; De Maria ML; Borges CL; Soares CM; Pedrino GR; Colugnati DB; Santos RA; Mendes EP; Ferreira AJ; Castro CH Life Sci; 2016 Jun; 155():63-9. PubMed ID: 27153779 [TBL] [Abstract][Full Text] [Related]
8. Activation of angiotensin-converting enzyme 2 (ACE2) attenuates allergic airway inflammation in rat asthma model. Dhawale VS; Amara VR; Karpe PA; Malek V; Patel D; Tikoo K Toxicol Appl Pharmacol; 2016 Sep; 306():17-26. PubMed ID: 27343405 [TBL] [Abstract][Full Text] [Related]
9. Activation of angiotensin-converting enzyme 2 improves cardiac electrical changes in ventricular repolarization in streptozotocin-induced hyperglycaemic rats. Coutinho DC; Monnerat-Cahli G; Ferreira AJ; Medei E Europace; 2014 Nov; 16(11):1689-96. PubMed ID: 24741027 [TBL] [Abstract][Full Text] [Related]
10. The potential actions of angiotensin-converting enzyme II (ACE2) activator diminazene aceturate (DIZE) in various diseases. Qaradakhi T; Gadanec LK; McSweeney KR; Tacey A; Apostolopoulos V; Levinger I; Rimarova K; Egom EE; Rodrigo L; Kruzliak P; Kubatka P; Zulli A Clin Exp Pharmacol Physiol; 2020 May; 47(5):751-758. PubMed ID: 31901211 [TBL] [Abstract][Full Text] [Related]
11. Antiglaucomatous effects of the activation of intrinsic Angiotensin-converting enzyme 2. Foureaux G; Nogueira JC; Nogueira BS; Fulgêncio GO; Menezes GB; Fernandes SO; Cardoso VN; Fernandes RS; Oliveira GP; Franca JR; Faraco AA; Raizada MK; Ferreira AJ Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4296-306. PubMed ID: 23702784 [TBL] [Abstract][Full Text] [Related]
12. Diminazene aceturate prevents nephropathy by increasing glomerular ACE2 and AT Goru SK; Kadakol A; Malek V; Pandey A; Sharma N; Gaikwad AB Br J Pharmacol; 2017 Sep; 174(18):3118-3130. PubMed ID: 28688122 [TBL] [Abstract][Full Text] [Related]
13. Diminazene attenuates pulmonary hypertension and improves angiogenic progenitor cell functions in experimental models. Shenoy V; Gjymishka A; Jarajapu YP; Qi Y; Afzal A; Rigatto K; Ferreira AJ; Fraga-Silva RA; Kearns P; Douglas JY; Agarwal D; Mubarak KK; Bradford C; Kennedy WR; Jun JY; Rathinasabapathy A; Bruce E; Gupta D; Cardounel AJ; Mocco J; Patel JM; Francis J; Grant MB; Katovich MJ; Raizada MK Am J Respir Crit Care Med; 2013 Mar; 187(6):648-57. PubMed ID: 23370913 [TBL] [Abstract][Full Text] [Related]
14. Beneficial Effects of the Angiotensin-Converting Enzyme 2 Activator Dize in Renovascular Hypertension. Kangussu LM; de Almeida TCS; Prestes TRR; de Andrade De Maria ML; da Silva Filha R; Vieira MAR; Silva ACSE; Ferreira AJ Protein Pept Lett; 2019; 26(7):523-531. PubMed ID: 30950337 [TBL] [Abstract][Full Text] [Related]
16. The beneficial effects of angiotensin-converting enzyme II (ACE2) activator in pulmonary hypertension secondary to left ventricular dysfunction. Chen IC; Lin JY; Liu YC; Chai CY; Yeh JL; Hsu JH; Wu BN; Dai ZK Int J Med Sci; 2020; 17(16):2594-2602. PubMed ID: 33029102 [TBL] [Abstract][Full Text] [Related]
17. Stimulation of the ACE2/Ang-(1-7)/Mas axis in hypertensive pregnant rats attenuates cardiovascular dysfunction in adult male offspring. Bessa ASM; Jesus ÉF; Nunes ADC; Pontes CNR; Lacerda IS; Costa JM; Souza EJ; Lino-Júnior RS; Biancardi MF; Dos Santos FCA; Pedrino GR; Colugnati DB; Mazaro-Costa R; Mendes EP; Castro CH Hypertens Res; 2019 Dec; 42(12):1883-1893. PubMed ID: 31506648 [TBL] [Abstract][Full Text] [Related]
18. [ACE2 agonist DIZE alleviates lung injury induced by limb ischemia-reperfusion in mice]. Li SM; Wang XY; Liu F; Yang XH Sheng Li Xue Bao; 2018 Apr; 70(2):175-183. PubMed ID: 29691582 [TBL] [Abstract][Full Text] [Related]
19. Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions. Burchill LJ; Velkoska E; Dean RG; Griggs K; Patel SK; Burrell LM Clin Sci (Lond); 2012 Dec; 123(11):649-58. PubMed ID: 22715807 [TBL] [Abstract][Full Text] [Related]